MedPath

Detection of Ileoanal Pouch/Reservoir Adenomas

Not yet recruiting
Conditions
Adenomatous Polyps
Registration Number
NCT05954949
Lead Sponsor
Jean Christophe Saurin
Brief Summary

The detection of adenomas is the basis for the follow-up of patients with familial adenomatous polyposis, after colectomy, with a remnant rectum or an ileal pouch. The optimal method for the adenomas detection is not defined yet. Despite the proven effectiveness of indigo-carmine in different indications dye chromoendoscopy is not used in a consensual way at the international level. The situation of the ileal pouch is specific as adenomas have a usually flat shape and are much more difficult to identify than in the situation of a remnant rectum, even in the situation of \> 5 mm adenomas that should be resected.

Our hypothesis is that indigo-carmine can improve adenomas detection, including \> 5 mm adenomas, in patients with a an ileal pouch after colectomy improving the effectiveness of surveillance programs and potentially reducing the risk of cancer in this population.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients with familial adenomatous polyposis
  • Ileo-anal anastomosis with pouch reservoir
  • Quality of the final preparation = 3 (excellent) on the studied area
  • Films made under optimal conditions for the 3 staining methods
Exclusion Criteria
  • Patient with no familial adenomatous polyposis
  • Patient without Ileo-anal anastomosis reservoir
  • Insufficient quality of the final preparation <3
  • Absence of films made under optimal conditions for the 3 staining methods

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Average number of ileal pouch/reservoir adenomas6 months after colonoscopy

Average number of ileal pouch/reservoir adenomas detected according to the endoscopic mode (staining or not, virtual or not) based on a paired review of the films with final consensus in case of discordance

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.